IntelGenx To Present at Biotech Showcase(TM) 2018
Jan 04, 2018 13:00 pm UTC| Business
SAINT-LAURENT, Quebec, Jan. 04, 2018 -- IntelGenx Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") today announced that its President and Chief Executive Officer, Dr. Horst Zerbe, is scheduled to...
Asterias Biotherapeutics Reports Milestone Targets for 2018
Jan 04, 2018 12:51 pm UTC| Business
FREMONT, Calif., Jan. 04, 2018 -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company pioneering the field of regenerative medicine, today provided its 2018 milestones targets for its spinal cord...
Jan 04, 2018 12:50 pm UTC| Business
NEW YORK, Jan. 04, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of A10 Networks, Inc....
Jan 04, 2018 12:40 pm UTC| Business
NEW YORK, Jan. 04, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of K2M Group...
Jan 04, 2018 12:39 pm UTC| Business
Dublin, Jan. 04, 2018 -- The "Growth Opportunities for Vinyl Flooring in the Global Construction Market" report has been added to Research and Markets' offering. The global vinyl flooring market is...
Amedisys Forges Collaborative Partnership with myNEXUS®
Jan 04, 2018 12:32 pm UTC| Business
BATON ROUGE, La., Jan. 04, 2018 -- Amedisys (NASDAQ:AMED), a leading healthcare at home company, announced today the Company has entered into a collaborative partnership with myNEXUS®, a leading post-acute technology...
Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer
Jan 04, 2018 12:32 pm UTC| Business
CAMBRIDGE, Mass., Jan. 04, 2018 -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for...